1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)ANNALS OF ONCOLOGY
2022Durvalumab +/− Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase III POSEIDON StudyPNEUMOLOGIE
2022Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03JOURNAL OF CLINICAL ONCOLOGY
2022Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling JOURNAL OF CLINICAL MEDICINE
2022Diagnostic evaluation of endoscopic ultrasonography with submucosal saline injection for differentiating between T1a and T1b early gastric cancer WORLD JOURNAL OF GASTROENTEROLOGY
2022Development of a Scoring System to Differentiate Severe Fever with Thrombocytopenia Syndrome from Scrub Typhus VIRUSES-BASEL
2022Delirium screening in critically ill patients: validation of the Korean version of the 4 A’s TestEUROPEAN RESPIRATORY JOURNAL
2022Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparisonGASTROINTESTINAL ENDOSCOPY
2022Deep Learning Improves Prediction of Cardiovascular Disease-Related Mortality and Admission in Patients with Hypertension: Analysis of the Korean National Health Information Database JOURNAL OF CLINICAL MEDICINE
2022Deciphering changes in the incidence of the Guillain-Barré syndrome during the COVID-19 pandemic: a nationwide time-series correlation study BMJ NEUROLOGY OPEN
2022Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01ANNALS OF ONCOLOGY
2022Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study ANNALS OF ONCOLOGY
2022Co- occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): Biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trialANNALS OF ONCOLOGY
2022Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY
2022Clinical features and long-term prognosis of acute fibrinous and organizing pneumonia histologically confirmed by surgical lung biopsy BMC PULMONARY MEDICINE
2022Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis EMERGING MICROBES & INFECTIONS
2022Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease GUT AND LIVER
2022Clinical characteristics, treatment patterns and outcomes of EGFR exon 20 insertion and other EGFR mutations in Korean aNSCLC patientsANNALS OF ONCOLOGY
2022Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study GUT AND LIVER

Recent Submissions

Browse

Links